Table of Contents 1 Study Coverage 1.1 Motion Sickness Drugs Product Introduction 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Motion Sickness Drugs Market Size Growth Rate by Type 1.4.2 Anticholinergic 1.4.3 Antihistamines 1.4.4 Others 1.5 Market by Application 1.5.1 Global Motion Sickness Drugs Market Size Growth Rate by Application 1.5.2 Adults 1.5.3 Children 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Motion Sickness Drugs Market Size 2.1.1 Global Motion Sickness Drugs Revenue 2014-2025 2.1.2 Global Motion Sickness Drugs Sales 2014-2025 2.2 Motion Sickness Drugs Growth Rate by Regions 2.2.1 Global Motion Sickness Drugs Sales by Regions 2.2.2 Global Motion Sickness Drugs Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Motion Sickness Drugs Sales by Manufacturers 3.1.1 Motion Sickness Drugs Sales by Manufacturers 3.1.2 Motion Sickness Drugs Sales Market Share by Manufacturers 3.2 Motion Sickness Drugs Revenue by Manufacturers 3.2.1 Motion Sickness Drugs Revenue by Manufacturers (2014-2019) 3.2.2 Motion Sickness Drugs Revenue Share by Manufacturers (2014-2019) 3.3 Motion Sickness Drugs Price by Manufacturers 3.4 Motion Sickness Drugs Manufacturing Base Distribution, Product Types 3.4.1 Motion Sickness Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Motion Sickness Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Motion Sickness Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Motion Sickness Drugs Sales by Type 4.2 Global Motion Sickness Drugs Revenue by Type 4.3 Motion Sickness Drugs Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Motion Sickness Drugs Breakdown Data by Application 6 North America 6.1 North America Motion Sickness Drugs by Country 6.1.1 North America Motion Sickness Drugs Sales by Country 6.1.2 North America Motion Sickness Drugs Revenue by Country 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Motion Sickness Drugs by Type 6.3 North America Motion Sickness Drugs by Application 7 Europe 7.1 Europe Motion Sickness Drugs by Country 7.1.1 Europe Motion Sickness Drugs Sales by Country 7.1.2 Europe Motion Sickness Drugs Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Motion Sickness Drugs by Type 7.3 Europe Motion Sickness Drugs by Application 8 Asia Pacific 8.1 Asia Pacific Motion Sickness Drugs by Region 8.1.1 Asia Pacific Motion Sickness Drugs Sales by Region 8.1.2 Asia Pacific Motion Sickness Drugs Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Thailand 8.1.10 Malaysia 8.1.11 Philippines 8.1.12 Vietnam 8.2 Asia Pacific Motion Sickness Drugs by Type 8.3 Asia Pacific Motion Sickness Drugs by Application 9 Central & South America 9.1 Central & South America Motion Sickness Drugs by Country 9.1.1 Central & South America Motion Sickness Drugs Sales by Country 9.1.2 Central & South America Motion Sickness Drugs Revenue by Country 9.1.3 Brazil 9.2 Central & South America Motion Sickness Drugs by Type 9.3 Central & South America Motion Sickness Drugs by Application 10 Middle East and Africa 10.1 Middle East and Africa Motion Sickness Drugs by Country 10.1.1 Middle East and Africa Motion Sickness Drugs Sales by Country 10.1.2 Middle East and Africa Motion Sickness Drugs Revenue by Country 10.1.3 Turkey 10.1.4 GCC Countries 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Motion Sickness Drugs by Type 10.3 Middle East and Africa Motion Sickness Drugs by Application 11 Company Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Details 11.1.2 Company Business Overview 11.1.3 GlaxoSmithKline Motion Sickness Drugs Sales, Revenue and Gross Margin (2014-2019) 11.1.4 GlaxoSmithKline Motion Sickness Drugs Products Offered 11.1.5 GlaxoSmithKline Recent Development 11.2 Prestige Brands 11.2.1 Prestige Brands Company Details 11.2.2 Company Business Overview 11.2.3 Prestige Brands Motion Sickness Drugs Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Prestige Brands Motion Sickness Drugs Products Offered 11.2.5 Prestige Brands Recent Development 11.3 WellSpring Pharmaceutical Corporation 11.3.1 WellSpring Pharmaceutical Corporation Company Details 11.3.2 Company Business Overview 11.3.3 WellSpring Pharmaceutical Corporation Motion Sickness Drugs Sales, Revenue and Gross Margin (2014-2019) 11.3.4 WellSpring Pharmaceutical Corporation Motion Sickness Drugs Products Offered 11.3.5 WellSpring Pharmaceutical Corporation Recent Development 11.4 Baxter International 11.4.1 Baxter International Company Details 11.4.2 Company Business Overview 11.4.3 Baxter International Motion Sickness Drugs Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Baxter International Motion Sickness Drugs Products Offered 11.4.5 Baxter International Recent Development 11.5 Mylan 11.5.1 Mylan Company Details 11.5.2 Company Business Overview 11.5.3 Mylan Motion Sickness Drugs Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Mylan Motion Sickness Drugs Products Offered 11.5.5 Mylan Recent Development 11.6 Sandoz 11.6.1 Sandoz Company Details 11.6.2 Company Business Overview 11.6.3 Sandoz Motion Sickness Drugs Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Sandoz Motion Sickness Drugs Products Offered 11.6.5 Sandoz Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Details 11.7.2 Company Business Overview 11.7.3 Pfizer Motion Sickness Drugs Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Pfizer Motion Sickness Drugs Products Offered 11.7.5 Pfizer Recent Development 11.8 Myungmoon Pharm 11.8.1 Myungmoon Pharm Company Details 11.8.2 Company Business Overview 11.8.3 Myungmoon Pharm Motion Sickness Drugs Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Myungmoon Pharm Motion Sickness Drugs Products Offered 11.8.5 Myungmoon Pharm Recent Development 11.9 Caleb Pharmaceuticals 11.9.1 Caleb Pharmaceuticals Company Details 11.9.2 Company Business Overview 11.9.3 Caleb Pharmaceuticals Motion Sickness Drugs Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Caleb Pharmaceuticals Motion Sickness Drugs Products Offered 11.9.5 Caleb Pharmaceuticals Recent Development 12 Future Forecast 12.1 Motion Sickness Drugs Market Forecast by Regions 12.1.1 Global Motion Sickness Drugs Sales Forecast by Regions 2019-2025 12.1.2 Global Motion Sickness Drugs Revenue Forecast by Regions 2019-2025 12.2 Motion Sickness Drugs Market Forecast by Type 12.2.1 Global Motion Sickness Drugs Sales Forecast by Type 2019-2025 12.2.2 Global Motion Sickness Drugs Revenue Forecast by Type 2019-2025 12.3 Motion Sickness Drugs Market Forecast by Application 12.4 North America Motion Sickness Drugs Forecast 12.5 Europe Motion Sickness Drugs Forecast 12.6 Asia Pacific Motion Sickness Drugs Forecast 12.7 Central & South America Motion Sickness Drugs Forecast 12.8 Middle East and Africa Motion Sickness Drugs Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Motion Sickness Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Motion Sickness Drugs Product Picture Table Motion Sickness Drugs Market Segments Table Key Manufacturers Motion Sickness Drugs Covered Table Global Motion Sickness Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$) Figure Global Motion Sickness Drugs Sales Market Share by Type in 2018 & 2025 Figure Anticholinergic Product Picture Table Major Manufacturers of Anticholinergic Figure Antihistamines Product Picture Table Major Manufacturers of Antihistamines Figure Others Product Picture Table Major Manufacturers of Others Table Global Motion Sickness Drugs Market Size Growth Rate by Application 2019-2025 (K Units) Figure Global Motion Sickness Drugs 4900 Sales Market Share by Application in 2018 Figure Adults Figure Children Figure Motion Sickness Drugs Report Years Considered Figure Global Motion Sickness Drugs Market Size 2014-2025 (Million US$) Figure Global Motion Sickness Drugs Sales 2014-2025 (K Units) Table Global Motion Sickness Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Motion Sickness Drugs Sales by Regions 2014-2019 (K Units) Table Global Motion Sickness Drugs Sales Market Share by Regions 2014-2019 Figure Global Motion Sickness Drugs Sales Market Share by Regions 2014-2019 Figure 2018 Global Motion Sickness Drugs Sales Market Share by Regions Table Global Motion Sickness Drugs Revenue by Regions 2014-2019 (Million US$) Table Global Motion Sickness Drugs Revenue Market Share by Regions 2014-2019 Figure Global Motion Sickness Drugs Revenue Market Share by Regions 2014-2019 Figure 2018 Global Motion Sickness Drugs Revenue Market Share by Regions Table Global Motion Sickness Drugs Sales by Manufacturers (2014-2019) (K Units) Table Global Motion Sickness Drugs Sales Share by Manufacturers (2014-2019) Figure Global Motion Sickness Drugs Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Motion Sickness Drugs Revenue by Manufacturers (2014-2019) (Million USD) Table Motion Sickness Drugs Revenue Share by Manufacturers (2014-2019) Figure Motion Sickness Drugs Value Share by Manufacturers in 2018 Table Key Manufacturers Motion Sickness Drugs Price (2014-2019) (USD/Unit) Table Motion Sickness Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Motion Sickness Drugs Product Type Table Date of International Manufacturers Enter into Motion Sickness Drugs Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Motion Sickness Drugs Sales by Type (2014-2019) (K Units) Table Global Motion Sickness Drugs Sales Share by Type (2014-2019) Figure Global Motion Sickness Drugs Sales Market Share by Type (2014-2019) Figure Global Motion Sickness Drugs Sales Market Share by Type in 2018 Table Global Motion Sickness Drugs Revenue by Type (2014-2019) (Million US$) Table Global Motion Sickness Drugs Revenue Share by Type (2014-2019) Figure Global Motion Sickness Drugs Revenue Market Share by Type (2014-2019) Figure Global Motion Sickness Drugs Revenue Market Share by Type in 2018 Table Motion Sickness Drugs Price by Type 2014-2019 (USD/Unit) Table Global Motion Sickness Drugs Sales by Application (2014-2019) (K Units) Table Global Motion Sickness Drugs Sales Share by Application (2014-2019) Figure Global Sales Motion Sickness Drugs Market Share by Application (2014-2019) Figure Global Sales Motion Sickness Drugs Market Share by Application in 2018 Figure North America Motion Sickness Drugs Sales Growth Rate 2014-2019 (K Units) Figure North America Motion Sickness Drugs Revenue Growth Rate 2014-2019 (Million US$) Table North America Motion Sickness Drugs Sales by Country (2014-2019) (K Units) Table North America Motion Sickness Drugs Sales Market Share by Country (2014-2019) Figure 2018 North America Motion Sickness Drugs Sales Market Share by Country Table North America Motion Sickness Drugs Revenue by Country (2014-2019) (Million US$) Table North America Motion Sickness Drugs Revenue Market Share by Country (2014-2019) Figure 2018 North America Motion Sickness Drugs Revenue Market Share by Country Figure United States Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure United States Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Canada Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Canada Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Mexico Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Table North America Motion Sickness Drugs Sales by Type (2014-2019) (K Units) Table North America Motion Sickness Drugs Sales Market Share by Type (2014-2019) Figure 2018 North America Motion Sickness Drugs Market Share by Type Table North America Motion Sickness Drugs Sales by Application (2014-2019) (K Units) Table North America Motion Sickness Drugs Sales Market Share by Application (2014-2019) Figure 2018 North America Motion Sickness Drugs Market Share by Application Figure Europe Motion Sickness Drugs Sales Growth Rate 2014-2019 (K Units) Figure Europe Motion Sickness Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Europe Motion Sickness Drugs Sales by Country (2014-2019) (K Units) Table Europe Motion Sickness Drugs Sales Market Share by Country (2014-2019) Figure 2018 Europe Motion Sickness Drugs Sales Market Share by Country Table Europe Motion Sickness Drugs Revenue by Country (2014-2019) (Million US$) Table Europe Motion Sickness Drugs Revenue Market Share by Country (2014-2019) Figure 2018 Europe Motion Sickness Drugs Revenue Market Share by Country Figure Germany Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Germany Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure France Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure France Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure UK Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure UK Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Italy Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Russia Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Europe Motion Sickness Drugs Sales by Type (2014-2019) (K Units) Table Europe Motion Sickness Drugs Sales Market Share by Type (2014-2019) Figure 2018 Europe Motion Sickness Drugs Market Share by Type Table Europe Motion Sickness Drugs Sales by Application (2014-2019) (K Units) Table Europe Motion Sickness Drugs Sales Market Share by Application (2014-2019) Figure 2018 Europe Motion Sickness Drugs Market Share by Application Figure Asia Pacific Motion Sickness Drugs Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Motion Sickness Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Motion Sickness Drugs Sales by Region (2014-2019) (K Units) Table Asia Pacific Motion Sickness Drugs Sales Market Share by Region (2014-2019) Figure 2018 Asia Pacific Motion Sickness Drugs Sales Market Share by Region Table Asia Pacific Motion Sickness Drugs Revenue by Region (2014-2019) (Million US$) Table Asia Pacific Motion Sickness Drugs Revenue Market Share by Region (2014-2019) Figure 2018 Asia Pacific Motion Sickness Drugs Revenue Market Share by Country Figure China Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure China Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Japan Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure South Korea Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure South Korea Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure India Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure India Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Australia Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Thailand Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Philippines Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Motion Sickness Drugs Sales by Type (2014-2019) (K Units) Table Asia Pacific Motion Sickness Drugs Sales Market Share by Type (2014-2019) Figure 2018 Asia Pacific Motion Sickness Drugs Market Share by Type Table Asia Pacific Motion Sickness Drugs Sales by Application (2014-2019) (K Units) Table Asia Pacific Motion Sickness Drugs Sales Market Share by Application (2014-2019) Figure 2018 Asia Pacific Motion Sickness Drugs Market Share by Application Figure Central & South America Motion Sickness Drugs Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Motion Sickness Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Motion Sickness Drugs Sales by Country (2014-2019) (K Units) Table Central & South America Motion Sickness Drugs Sales Market Share by Country (2014-2019) Figure 2018 Central & South America Motion Sickness Drugs Sales Market Share by Country Table Central & South America Motion Sickness Drugs Revenue by Country (2014-2019) (Million US$) Table Central & South America Motion Sickness Drugs Revenue Market Share by Country (2014-2019) Figure 2018 Central & South America Motion Sickness Drugs Revenue Market Share by Country Figure Brazil Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Brazil Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Motion Sickness Drugs Sales by Type (2014-2019) (K Units) Table Central & South America Motion Sickness Drugs Sales Market Share by Type (2014-2019) Figure 2018 Central & South America Motion Sickness Drugs Market Share by Type Table Central & South America Motion Sickness Drugs Sales by Application (2014-2019) (K Units) Table Central & South America Motion Sickness Drugs Sales Market Share by Application (2014-2019) Figure 2018 Central & South America Motion Sickness Drugs Market Share by Application Figure Middle East and Africa Motion Sickness Drugs Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Motion Sickness Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Motion Sickness Drugs Sales by Country (2014-2019) (K Units) Table Middle East and Africa Motion Sickness Drugs Sales Market Share by Country (2014-2019) Figure 2018 Middle East and Africa Motion Sickness Drugs Sales Market Share by Country Table Middle East and Africa Motion Sickness Drugs Revenue by Country (2014-2019) (Million US$) Table Middle East and Africa Motion Sickness Drugs Revenue Market Share by Country (2014-2019) Figure 2018 Middle East and Africa Motion Sickness Drugs Revenue Market Share by Country Figure Turkey Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Turkey Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure GCC Countries Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure Egypt Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units) Figure South Africa Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Motion Sickness Drugs Sales by Type (2014-2019) (K Units) Table Middle East and Africa Motion Sickness Drugs Sales Market Share by Type (2014-2019) Figure 2018 Middle East and Africa Motion Sickness Drugs Market Share by Type Table Middle East and Africa Motion Sickness Drugs Sales by Application (2014-2019) (K Units) Table Middle East and Africa Motion Sickness Drugs Sales Market Share by Application (2014-2019) Figure 2018 Middle East and Africa Motion Sickness Drugs Market Share by Application Table GlaxoSmithKline Company Details Table GlaxoSmithKline Motion Sickness Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline Recent Development Table Prestige Brands Company Details Table Prestige Brands Motion Sickness Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Prestige Brands Recent Development Table WellSpring Pharmaceutical Corporation Company Details Table WellSpring Pharmaceutical Corporation Motion Sickness Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table WellSpring Pharmaceutical Corporation Recent Development Table Baxter International Company Details Table Baxter International Motion Sickness Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Baxter International Recent Development Table Mylan Company Details Table Mylan Motion Sickness Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Mylan Recent Development Table Sandoz Company Details Table Sandoz Motion Sickness Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sandoz Recent Development Table Pfizer Company Details Table Pfizer Motion Sickness Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Recent Development Table Myungmoon Pharm Company Details Table Myungmoon Pharm Motion Sickness Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Myungmoon Pharm Recent Development Table Caleb Pharmaceuticals Company Details Table Caleb Pharmaceuticals Motion Sickness Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Caleb Pharmaceuticals Recent Development Table Global Motion Sickness Drugs Sales Forecast by Regions 2019-2025 (K Units) Table Global Motion Sickness Drugs Sales Market Share Forecast by Regions 2019-2025 Table Global Motion Sickness Drugs Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Motion Sickness Drugs Revenue Market Share Forecast by Regions 2019-2025 Table Global Motion Sickness Drugs Sales Forecast by Type 2019-2025 (K Units) Table Global Motion Sickness Drugs Sales Market Share Forecast by Type 2019-2025 Table Global Motion Sickness Drugs Revenue Forecast by Type 2019-2025 (Million US$) Table Global Motion Sickness Drugs Revenue Market Share Forecast by Type 2019-2025 Table Global Motion Sickness Drugs Sales Forecast by Application 2019-2025 (K Units) Table Global Motion Sickness Drugs Sales Market Share Forecast by Application 2019-2025 Figure North America Motion Sickness Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Motion Sickness Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Motion Sickness Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Motion Sickness Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Motion Sickness Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Motion Sickness Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Motion Sickness Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Motion Sickness Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Motion Sickness Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Motion Sickness Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Key Opportunities and Drivers: Impact Analysis (2019-2025) Table Key Challenges Table Market Risks Figure Porter's Five Forces Analysis Table Motion Sickness Drugs Value Chain Table Motion Sickness Drugs Customers List Figure Channels of Distribution Table Motion Sickness Drugs Distributors List Figure Distributors Profiles Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Figure Key Executives Interviewed Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GlaxoSmithKline Prestige Brands WellSpring Pharmaceutical Corporation Baxter International Mylan Sandoz Pfizer Myungmoon Pharm Caleb Pharmaceuticals